UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
ADVANTAGE LIFE PRODUCTS
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
00755M504
(CUSIP Number)
Tom E. Zegan
9903 Santa Monica Blvd. - Suite 748
Beverly Hills, Ca. 90212
1.888.843.4284
If this filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing
schedule because of Rule 13d-1 (b) (3) or (4) check the following box [ ]
Check the following box if a fee is being paid with this statement. [x] (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the notes)
________________________________________________________________________________
SCHEDULE 13D
________________________________________________________________________________
CUSIP Number - 00755M504 Page 2 of 4 Pages
________________________________________________________________________________
1) Name of reporting person - Tom E. Zegan
________________________________________________________________________________
2) Check the appropriate box if a member of a group - N/A
________________________________________________________________________________
3) SEC use only
________________________________________________________________________________
4) Source of funds - Private Funds
________________________________________________________________________________
5) Check box if disclosure of legal proceedings is required pursuant to items
2(d) or 2 (e) - N/A
________________________________________________________________________________
6) Citizenship or place of organization - United States of America
________________________________________________________________________________
Number of 7) Sole voting power - 300,000
_________________________________________________________________
Shares
8) Shared voting power - None
Beneficially _________________________________________________________________
Owned 9) Sole dispositive power - 300,000
_________________________________________________________________
By Each
10) Shared dispositive power - None
Reporting _________________________________________________________________
Person With 11) Aggregated amount beneficially - 300,000
________________________________________________________________________________
12) Check if the aggregate amount in row 11 excludes certain shares - N/A
________________________________________________________________________________
13) Percent of class represented by amount in box 11 - 61.7%
________________________________________________________________________________
14) Type of reporting person - Individual
________________________________________________________________________________
Item 1. Security and Issuer Common Stock
Name of Company Advantage Life Products, Inc.
Address of Record 1509 S. Florida Avenue
Lakeland, Fl. 33803
Item 2. Identity and Background.
(a) Tom E. Zegan
(b) 9903 Santa Monica Blvd. - Suite 748
Beverly Hills, Ca. 90212
(c) Private Investor
(d) Mr. Zegan has not during the last five years been convicted in a
criminal proceeding.
(e) Mr. Zegan has not during the last five years been a party to a civil
proceeding of a judicial or administrative body of competent
jurisdiction which resulted in his being subject to a judgment,
decree, or final order enjoining future violations of, or
prohibiting or mandating activities subject to, federal state
securities laws or finding any violation with respect to such laws.
(f) The person listed in this Item 2 or Schedule I hereto is a citizen
of the United States of America.
Item 3. Source and amount of funds or other consideration.
Personal funds -- $32,310.00
Item 4. Purpose of transaction.
(a) All shares of common stock have been acquired for the purpose of
obtaining majority stake in the issuers outstanding shares of
record and to sue issuer for a proxy.
(b) It is the desire of the reporting individual to uncover and
determine any and all assets of the issuer; to liquidate said assets
for the benefit of it's registered shareholders. After which, to
reorganize and merge a private company back into it's place.
(c) Any and all assets of issuer are to be uncovered and liquidation
will be determined at that time.
(d) The current Board of Directors of issuer will be replaced with a new
Board of Directors made up of current shareholders of issuer's
common stock. Management will be left intact.
(e) It is not known if there will be any material change in the present
capitalization or dividend policy of the issuer at this time.
(f) Any other material change in the issuer's business or corporate
structure, along with plans or proposals to make any changes in it's
investment policy for which a vote is required by section 13 of the
Investment Company Act of 1940 will be determined at a later date.
(g) Any changes in the issuer's charter, bylaws or instruments
corresponding thereto or other actions which may impede
the acquisition or control of the issuer by any person are being
looked into at this time and will be made public if determined.
Item 5. Interest in securities of the issuer.
(a) The 300,000 shares of company common stock beneficially owned by
the reporting person constitute 61.7% of the outstanding shares of
company common stock (based upon an aggregate of 486,000 outstanding
shares of company common stock as of November 12, 1997)
(b) The 300,000 shares of common stock are solely owned by the reporting
person. He alone has sole power to vote or dispose thereof.
(c) N/A
(d) N/A
Item 6. Contracts, arrangements, understandings or relationships with respect to
securities of issuer.
Neither the reporting person, nor (to the best knowledge of the
reporting person) any of the executive officers and directors, has any
contract, agreement, understanding or relationship (legal or otherwise)
with any person with respect to any securities of the company, including
but not limited to the transfer or voting of any of such securities,
finder's fees, joint ventures, loan or option arrangements, puts or
calls, guarantees of profits, division of profits or loss or the giving
or the withholding of proxies.
Item 7. Material to be filed as Exhibits. None
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Intentional misstatements or omissions of fact constitute Federal criminal
violations (See 18 U.S.C. 1001)
July 24, 1998
Tom E. Zegan
By: Tom E. Zegan
